HYPERPROGRESSIVE DISEASE IN A NSCLC PATIENT AFTER ANTI-PD-L1 ANTIBODY THERAPY DESPITE TO GOOD RESPONSE OF ANTI- PD-1 ANTIBODY WITH TEMPORARY INTERRUPTION DUE TO IRAE.
Session Name
AS16 - Lung Cancer
Presentation Type
Late Breaking Case Report